Bringing a first product to market is a high-stakes milestone that defines a...
Friday, 19 Sep 2025
Phase I-IV solutions tailored to help you deliver life-changing therapies with speed and efficiency
The PPD™ clinical research business of Thermo Fisher Scientific provides end-to-end, full-service solutions and customized strategies that cover every aspect of clinical testing. Our experienced team takes pride in its ability to consult and plan for every step of developing and testing medical therapies. We use our expertise and resources as a global CRO solutions provider to help you advance your drug development program.
Our experts begin by envisioning and planning for commercialization and market acceptance well before the first patient is enrolled in a clinical trial. And as testing is underway, we design for post-approval, real-world patient observation that may lead to new ideas and products.
We have networks of investigators, clinicians, patients and testing sites across the globe. We tap our regulatory expertise, data and business analytics, and proven laboratory services to work effectively with pharmaceutical, biotech, medical device, academic, government and public health organizations in clinical testing.
We understand that each customer has unique needs and work to design innovative, custom solutions across the full drug development life cycle.
No results found.
Friday, 19 Sep 2025
Monday, 26 May 2025
Monday, 26 May 2025
